ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Clinical trials for ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection could save heart muscle after attack
Disease control Recruiting nowThis study tests a new medicine called SGC001 in people who have had a serious type of heart attack (anterior STEMI) and are scheduled for a procedure to open blocked arteries. The goal is to see if SGC001 can reduce the size of the heart damage and lower the chance of future hea…
Matched conditions: ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE2 • Sponsor: Beijing Sungen Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Asthma drug could shield hearts after attack, new trial hopes
Disease control Recruiting nowThis phase 3 trial tests whether montelukast, a common asthma drug, can reduce heart damage in people having a heart attack. 512 patients with a specific type of heart attack will receive either montelukast or a placebo daily for 3 months. The goal is to see if the drug prevents …
Matched conditions: ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC